Navigation Links
Report Finds an Alarming Number of Chronically Ill Patients - Over 93 Percent - Reporting Medical Debt Crisis Issues in 2008 Have Some Form of Insurance
Date:4/29/2009

New trend findings of "underinsured" patients based on successful resolution of more than 48,000 cases by national, non-profit Patient Advocate Foundation in 2008

NEWPORT NEWS, Va., April 29 /PRNewswire-USNewswire/ -- Patient Advocate Foundation (PAF) - a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases - today released their annual Patient Data Analysis Report (PDAR), which includes detailed analysis of general and specific healthcare access and insurance trends at the national and state-specific level. Regarded as a thorough and reliable resource by policymakers, healthcare providers, stakeholders and other members of the healthcare community, this expert data analysis offers a comprehensive summary of issues impacting Americans' access to healthcare.

PAF is on the frontlines of the healthcare access battle millions of Americans fight every day. Last year alone, PAF received in excess of 9.5 million contacts from patients, family members and care professionals requesting information and assistance. PAF's professional senior patient navigators successfully managed 48,369 cases for patients that required direct, sustained mediation and arbitration services. Globally, more than sixty percent of all patients who contacted PAF in 2008 reported debt crisis issues as their primary concern. Ninety-three percent of these patients were insured through plans, but were still unable to obtain physician-prescribed healthcare despite coverage, reflecting an alarming trend of medical debt crisis issues in the nation's healthcare system. Nearly eighty percent of PAF patients are cancer patients. The remaining twenty percent have chronic diseases including diabetes, COPD, hepatitis, asthma and osteoporosis.


'/>"/>
SOURCE Patient Advocate Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Archi-Tech InView Now Supports Managed Care Data, Offering an Interactive Dashboard for On-Demand Sales Planning and Reporting
2. U.S. Reports First Swine Flu Death
3. Endo Pharmaceuticals Reports First Quarter 2009 Financial Results
4. Wyeth Reports Earnings Results for the 2009 First Quarter
5. Medifast Reports Record First Quarter 2009 Financial Results
6. New American Lung Association Report Finds 60 Percent of Americans Live in Areas Where Air is Dirty Enough to Endanger Lives
7. Minnesotas Grades Tumble In Latest American Lung Association State of the Air Report
8. Fargo Named Americas Cleanest City in American Lung Associations State of the Air Report
9. Claimsnet.com Reports First Quarter 2009 Results
10. Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results
11. Harvard Medical School Releases Special Health Report on Swine Flu
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Express Scripts Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of WellPoint's NextRx Subsidiaries 2Health News:CVS/pharmacy Introduces New Coupon Center on CVS.com 2Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 2Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 3Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 4Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 5Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 6Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 2Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 3Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 4Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 5Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 6Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 7Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 8Health News:iUniverse Hosts Canadian Storytellers, Cystic Fibrosis Awareness Advocate for BookExpo America 2009 Book Signings 2Health News:New Website, ElasticBandageStore.com, Offers Elastic Bandages at Wholesale Prices 2
Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Marc Russo Named Vice President of Senior Markets at Blue Shield of California 57132 1Marc Russo Named Vice President of Senior Markets at Blue Shield of California 57132 2MUSC Researchers Concerned About Online Drug Availability 57128 1MUSC Researchers Concerned About Online Drug Availability 57128 2HealthSouth Declares Dividend on 6 5 25 Series A Convertible Perpetual Preferred Stock 57123 1